Status:
COMPLETED
Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Intention to Get SARS-CoV-2 Vaccination
Intention to Get SARS-CoV-2 Antibody Test
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objectives: To identify core and cross-time workplace hazards and worker's exposure prevention profile towards outbreaks in three non-healthcare work settings; to evaluate effectiveness of a theory-ba...
Eligibility Criteria
Inclusion
- currently being employed in Hong Kong
Exclusion
- who have history of physician-diagnosed cancer and sever chronic diseases
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT05197673
Start Date
March 15 2022
End Date
May 30 2023
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Shatin, New Territories, Hong Kong, 00000